June 29, 2018
On June 28, 2018, Forbes published Christopher Skroupa’s article, “Teddy Roosevelt: The German Way,” which focuses on the role of private shareholder litigation in helping monitor the capital markets for – and in some cases forcibly correct – instances of corporate misconduct before they take root as normal practice market-wide.
The article features an extensive interview with Dr. Andreas Zubord, an executive Board Member at Union Asset Management, who explains why one of Germany’s largest asset managers (with nearly $400 billion AUM) engages in private litigation as a means of keeping “managers of capital in line.” BLB&G represents Union Asset Management in several high-profile securities cases, including against Wells Fargo in the case arising from its fake accounts scandal, Equifax for its data-heist fiasco, and Allergan’s price-fixing scheme. BLB&G helped obtain $480 million for investors in Wells Fargo. The litigations against Allergan and Equifax are ongoing.
Dr. Zubrod asserts that shareholder rights litigation is “essential to sending a message to portfolio companies that we can and will hold wrongdoers accountable, and push for improved corporate governance across all industries.” Otherwise, the danger lies in that “misconduct not only becomes embedded into that company’s culture, but corrupt practices can become embedded into the culture of the market as whole.” According to Dr. Zubrod, strategic use of shareholder litigation is critical: “If we are in a position where we recognize we were now beyond the borders of reasonable business practice or judgment, then we will consider suing the company…Getting them to clean up their mess is of primary importance, but equally on our mind is seeking to prevent others from doing the same thing.”
BLB&G partner and head of the firm’s Corporate Governance practice, Mark Lebovitch, was also featured in the article. He praised Dr. Zubrod’s approach, calling it “his form of ‘Teddy Roosevelt activism.’ Speak-softly-but-carry-a-big-stick, if you will.” Mr. Lebovitch credits Dr. Zubrod for recognizing that “thoughtful and impactful litigation is a useful tool, and that the knowledge that Union will take action when managers cross the line has a deterrent power all its own.” Mr. Lebovitch underscored: “what we want in all of our cases is a significant result that forces the entire market to think about the broader implications of the case. If the outcome is sufficient and grabs the market’s attention, the conclusion will be that risk is not worth the price.”
External Link: Click here to download article. (link will open in a new window)
- Events BLB&G Hosts the Forum for Institutional Investors: Protecting Shareholder Rights in New Orleans, LA April 10, 2019 Learn More
- Publications "The Importance of Private Securities Litigation as a Complement to 'Worn Out' Regulators" by Scott Foglietta and Brittney Balser published in the New York Law Journal September 27, 2021 Learn More
- News Press Coverage: Williams Companies Stockholder Litigation Trial Challenging Novel Anti-Shareholder Corporate Governance Provision January 13, 2021 Learn More
- Events Rebecca Boon Guest Lectures at Columbia Law School on Sexual Harassment and Shareholder Litigation February 25, 2019 Learn More
- Publications "9th Circ. Case Could Gut Section 11 Shareholder Protections" by John C. Browne and Lauren Ormsbee published by Law360 May 26, 2021 Learn More
- Publications "Can We Rely On Shareholders To Compel Corporations To Meaningfully Act On ESG Issues?" by Rebecca Boon and John Rizio-Hamilton published by Responsible Investor September 1, 2021 Learn More
- Events Jeroen van Kwawegen Discusses Board Dynamics at Skytop Strategies’ Shareholder Activism 2019 January 24, 2019 Learn More
- Publications "Shareholder Litigation: Best Practices for Pension Funds" by Jeroen van Kwawegen and Anatoli van der Krans published by Financial Investigator December 4, 2020 Learn More
- Publications "Keeping Investors From Their Day in Court: The Fight to Shut Out Shareholders Continues with a New Twist" by Jacqueline Ma and Andrew Blumberg Published in The Advocate for Institutional Investors October 2019 Learn More